Gilead Sciences



Ebitda Zmiana Data
AbbVie USD 4.4B 2.52B 2025-03
Agios Pharmaceuticals USD -125797000 20.45M 2025-06
ALKERMES USD 126.53M 105.32M 2025-06
Alnylam Pharmaceuticals USD 18.83M 13.65M 2025-06
Amgen USD 3.6B 147M 2025-06
Biogen USD 1.01B 456.5M 2025-06
BioMarin Pharmaceutical USD 295.45M 49.49M 2025-06
Bristol-Myers Squibb USD 3.27B 1.63B 2025-06
Eli Lilly USD 7.5B 3.34B 2025-06
Gilead Sciences USD 3.4B 797M 2025-06
GlaxoSmithKline GBP 3.18B 45M 2025-06
Glaxosmithkline GBP 1.69B 1.6B 2024-12
Incyte USD 581.52M 358.87M 2025-06
J&J USD 7.88B 1.76B 2025-03
Merck USD 7.74B 625M 2025-03
Moderna USD -760000000 164M 2025-06
Neurocrine Biosciences USD 152.9M 121.6M 2025-06
Novartis USD 6.17B 339M 2025-06
Pfizer USD 5.32B 889M 2025-06
PTC Therapeutics USD 971.14M 970.07M 2025-03
Regeneron Pharmaceuticals USD 1.66B 926.5M 2025-06
Sanofi EUR 1.89B 971M 2025-06
Sarepta Therapeutics USD 126.42M 416.82M 2025-06
United Therapeutics USD 436.8M 34.2M 2025-06
Vertex Pharmaceuticals USD 1.34B 556.6M 2025-06


Gilead Sciences - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.